Casey Lynch
CIK 1770783 · Chief Executive Officer · last filed 2024-12-02
Casey Lynch is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for LBPH, was dated Dec 2, 2024. Across all open-market trades the lifetime net is −$4.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
12
-$4.41M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Director | — | $59.98 | — | $0 | 4 | 2024-12-02 |
| Quince Therapeutics, Inc. (CRTX) Delisted | Chief Executive Officer | 1,088,669 | $1.95 | $2.12M | -$4.41M | 7 | 2022-01-05 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-02 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-05-24 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-31 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | Quince Therapeutics, Inc. (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-19 | Quince Therapeutics, Inc. (CRTX) Delisted | Exer (M) | +60,000 | $27.6K | EDGAR |
| 2021-05-12 | Quince Therapeutics, Inc. (CRTX) Delisted | Sell (S) | −30,000 | -$1.04M | EDGAR |
| 2021-03-23 | Quince Therapeutics, Inc. (CRTX) Delisted | Sell (S) | −30,000 | -$1.07M | EDGAR |
| 2021-03-11 | — | Grant (A) | — | $0 | |
| 2021-02-03 | Quince Therapeutics, Inc. (CRTX) Delisted | Sell (S) | −60,000 | -$2.31M | EDGAR |